According to the latest report by IMARC Group, titled “Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global viral inactivation market size reached US$ 517.3 Million in 2021. Looking forward, IMARC Group expects the market to reach US$ 1,018.1 Million by 2027, exhibiting a growth rate (CAGR) of 11.7% during 2022-2027.
What is viral inactivation?
A virus is a type of infectious particle that invades cells and proliferates, resulting in various diseases. Viral inactivation is one of the first steps designed to enhance the efficacy and safety of biotherapeutic products. It helps stop the viruses in a given sample from contaminating the product by rendering them non-infectious or eliminating their presence entirely. The technique is widely used in the blood plasma in the food industries to prevent the presence of viral particles. Currently, several methods of viral inactivation are available in the market, depending on the various characteristics of the virus and the type of biotherapeutic product.
Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.
Get the Sample Report:: https://www.imarcgroup.com/viral-inactivation-market/requestsample
The global viral inactivation market is primarily driven by the rising number of chronic diseases, such as cancer, autoimmune diseases, and diabetes. In line with this, governments of various nations are heavily investing in the advancement of the healthcare industry. They are also introducing stringent regulatory standards in the development of biotherapeutic products at an early stage, which is providing a considerable boost to the market growth. Moreover, the surging concerns about the transmission of blood-borne viruses and the increasing investments in research and development (R&D) activities are boosting the market growth. Additionally, key players are developing new physical methods, such as gas plasma, supercritical fluids, and pulsed electric fields, to increase the suitability, reliability, and convenience of viral inactivation, which is accelerating the market growth.
 |
| Viral Inactivation Market Report |
Viral Inactivation Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape With Key Players:
The competitive landscape of the global viral inactivation market has been studied in the report with the detailed profiles of the key players operating in the market.
Key Players Included in Market Research Report:
- Charles River Laboratories (NYSE: CRL)
- Merck KGaA
- Parker Hannifin Corp
- Rad Source Technologies
- Sartorius AG
- SGS SA
- Terumo Corporation
- Texcell
- Vironova AB
- WuXi AppTec
Key Market Segmentation:
The report has segmented the global viral inactivation market on the basis of product, application, end use and region.
Breakup by Product:
- Reagents and Kits
- Systems
- Services
Breakup by Application:
- Vaccines and Therapeutics
- Stem Cell Products
- Blood and Blood Products
- Tissue and Tissue Products
- Cellular and Gene Therapy
Breakup by End Use:
- Pharmaceutical and Biotechnology Companies
- CROs
- Academic and Research Institutes
- Others
Regional Analysis:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=4115&flag=C
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Industry Trends
- Market Drivers and Success Factors
- The Impact of COVID-19 on the Global Market
- Value Chain Analysis
- Structure of the Global Market
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Read Also:
https://nboxoffice.com/aviation-test-equipment-market-share-size-demand-and-global-outlook-2023-2028
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email: sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
LinkedIn: https://www.linkedin.com/company/imarc-group
No comments:
Post a Comment